Allogene Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ALLO for the last quarter is 21.00 k USD, and it's 51.16% lower compared to the previous quarter. The net income of Q4 23 is -85.78 M USD.